HUP0102064A2 - Paroxetint tartalmazó új készítmény és eljárás az előállítására - Google Patents

Paroxetint tartalmazó új készítmény és eljárás az előállítására

Info

Publication number
HUP0102064A2
HUP0102064A2 HU0102064A HUP0102064A HUP0102064A2 HU P0102064 A2 HUP0102064 A2 HU P0102064A2 HU 0102064 A HU0102064 A HU 0102064A HU P0102064 A HUP0102064 A HU P0102064A HU P0102064 A2 HUP0102064 A2 HU P0102064A2
Authority
HU
Hungary
Prior art keywords
hemihydrate
preparation
formulation containing
novel formulation
conditions
Prior art date
Application number
HU0102064A
Other languages
English (en)
Hungarian (hu)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc. filed Critical Smithkline Beecham Plc.
Publication of HUP0102064A2 publication Critical patent/HUP0102064A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0102064A 1998-05-13 1999-05-13 Paroxetint tartalmazó új készítmény és eljárás az előállítására HUP0102064A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations

Publications (1)

Publication Number Publication Date
HUP0102064A2 true HUP0102064A2 (hu) 2002-05-29

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102064A HUP0102064A2 (hu) 1998-05-13 1999-05-13 Paroxetint tartalmazó új készítmény és eljárás az előállítására

Country Status (20)

Country Link
EP (1) EP1077682A2 (no)
JP (1) JP2002514591A (no)
KR (1) KR20010043574A (no)
CN (1) CN1308521A (no)
AP (1) AP2000002019A0 (no)
AU (1) AU3940999A (no)
BG (1) BG105010A (no)
BR (1) BR9910401A (no)
CA (1) CA2331871A1 (no)
EA (1) EA200001174A1 (no)
GB (1) GB9810181D0 (no)
HU (1) HUP0102064A2 (no)
ID (1) ID28019A (no)
IL (1) IL139594A0 (no)
NO (1) NO20005683L (no)
PL (1) PL344573A1 (no)
SK (1) SK17142000A3 (no)
TR (1) TR200003350T2 (no)
WO (1) WO1999058113A2 (no)
ZA (1) ZA200006562B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EP0952831A1 (en) * 1997-01-15 1999-11-03 Smithkline Beecham Plc Paroxetine compositions
CA2315088A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets

Also Published As

Publication number Publication date
WO1999058113A2 (en) 1999-11-18
TR200003350T2 (tr) 2001-03-21
IL139594A0 (en) 2002-02-10
ZA200006562B (en) 2002-02-13
CA2331871A1 (en) 1999-11-18
EP1077682A2 (en) 2001-02-28
WO1999058113A3 (en) 2000-02-17
PL344573A1 (en) 2001-11-05
EA200001174A1 (ru) 2001-06-25
CN1308521A (zh) 2001-08-15
JP2002514591A (ja) 2002-05-21
AP2000002019A0 (en) 2000-12-31
BR9910401A (pt) 2001-01-09
BG105010A (en) 2001-07-31
SK17142000A3 (sk) 2001-06-11
KR20010043574A (ko) 2001-05-25
NO20005683D0 (no) 2000-11-10
ID28019A (id) 2001-05-03
GB9810181D0 (en) 1998-07-08
NO20005683L (no) 2000-12-05
AU3940999A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DE69933149D1 (de) Substituierte cyclische verbindungen, verfahren zu ihrer herstellung sowie sie enthaltende pharmazeutische zusammensetzungen
DE69904302D1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
HUP0100669A2 (hu) Szerin proteázokat gátló peptidszármazékok és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
TR199901578T2 (xx) Klaritromisin form 0 kristali
BG103485A (en) Ketobanzamides as calpain inhibitors
DK0927161T3 (da) Substitueret cyklisk amin-metalloproteaseinhibitorer
ATE193888T1 (de) Nicht-steroidale sulfatase hemmer verbindungen
IL156280A0 (en) Crystalline forms of atorvastatin
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
TNSN04024A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
UA61124C2 (en) New pentasaccharides, a method for preparing thereof and pharmaceutical compositions containing them
HUP0102064A2 (hu) Paroxetint tartalmazó új készítmény és eljárás az előállítására
ATE399778T1 (de) Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20031137D0 (no) Fremgangsmåte for fremstilling av kirale forbindelser
MY118015A (en) Method of crystallizing a tetrahydropyridine derivative and crystalline forms thereby obtained
PL345916A1 (en) Novel compounds of 6-amino- or 6-hydrazin-sulphonyl-3-quinolinylphosphonic acid, method of obtaining them and pharmacological compositions containing such compounds